Astorg Acquires Pharmaceutical CDMO CordenPharma from ICIG

LGM Pharma Acquires Nexgen Pharma's Drug Product CDMO Business

July 23, 2020

Pharmaceuticals

LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, expanding LGM's CDMO capabilities and U.S.-based manufacturing footprint. Financial support for the transaction was provided by private equity firm New Harbor Capital; Nexgen Pharma sold its pharmaceutical CDMO unit to allow the company to focus on other healthcare segments.

GHO Capital Acquires Ardena, a European Early‑Stage CDMO

January 9, 2020

Pharmaceuticals

GHO Capital Partners LLP has acquired Ardena, a Belgium‑headquartered contract development and manufacturing organisation (CDMO) focused on early‑phase drug development, from Mentha Capital and existing management. GHO will partner with Ardena's management to accelerate international growth, broaden the company’s service offering and build a fully integrated early‑stage CDMO platform through organic and inorganic expansion.

Astorg Mid‑Cap Acquires Majority Stake in hg medical

May 5, 2023

Medical Devices

Astorg Mid‑Cap, the German arm of pan‑European private equity firm Astorg, has signed an agreement to acquire a majority stake in hg medical from NORD Holding. The transaction — terms undisclosed — will support management succession (COO Craig Bluett to become CEO, founder Johannes Hagenmeyer to move to an advisory role) and fund organic growth, capacity expansion and external M&A to scale hg medical's orthopaedic implant contract‑manufacturing platform across extremities and spine.

Altasciences Acquires Alliance Contract Pharma

February 27, 2020

Pharmaceuticals

Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.

Adragos Pharma Acquires Baccinex

February 6, 2025

Pharmaceuticals

Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.

PharmaLogic Holdings Corp. Acquires Majority Stake in Agilera Pharma AS

April 10, 2025

Pharmaceuticals

PharmaLogic Holdings Corp. has agreed to acquire a majority stake in Norway-based Agilera Pharma AS from the Institute for Energy Technology (IFE), creating an expanded, integrated global CDMO focused on radiopharmaceutical therapeutics. The deal strengthens PharmaLogic's manufacturing, development, and distribution capabilities for radiopharmaceuticals and is expected to close in June 2025, pending customary approvals.